DePuy LCS Knee Prosthesis Recalled for Higher Revision Rates
DePuy Orthopaedics is recalling LCS COMPLETE RPS knee inserts because they show higher revision rates in Australia when the patella is not resurfaced.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall is classified as FDA Class II, and the source describes a risk of harm (patello-femoral pain and potential secondary procedure) without reporting specific injuries or fatalities, fitting the 'High' severity criteria for risk-of-harm products where injury has not yet been reported.
Plain-English summary
DePuy Orthopaedics, Inc. is recalling 28,732 units of LCS COMPLETE RPS inserts, which are knee prosthesis components used in orthopedic surgery. The recall covers various sizes and all lots, identified by specific catalog numbers listed in the agency record.
The recall was initiated because the LCS COMPLETE RPS Knee System has higher rates of revision in Australia when the native patella is not resurfaced, compared to other unresurfaced posterior-stabilized implants. If the system is implanted without resurfacing the native patella, patients may experience patello-femoral pain, which could potentially require a secondary procedure.
The affected products were distributed nationwide in the United States and in several international countries, including Canada, Australia, Austria, Belgium, the UK, France, Greece, Ireland, Israel, Italy, Korea, Luxembourg, Malaysia, the Netherlands, New Zealand, Norway, South Africa, Switzerland, and Thailand. Healthcare providers and patients should consult with their orthopedic surgeons regarding the specific risks and potential need for follow-up care.
The recalled product
- Product
- LCS COMPLETE RPS inserts, various sizes. Knee prosthesis component for orthopedic surgery.
- Manufacturer
- DePuy Orthopaedics, Inc.
- Hazard
- Affected units
- 28,732
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by DePuy Orthopaedics, Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · DePuy Orthopaedics, Inc.
See all →- HighATTUNE AFFIXIUM Knee Implant Component Recalled for Incorrect Labeling
FDA (Devices) · 2024-04-10
- HighAttune Revision Limb Preservation System Tibial Insert Recalled for Over-Irradiation
FDA (Devices) · 2023-03-29
- HighDePuy Attune Tibial Insert Recalled for Excessive Radiation Exposure
FDA (Devices) · 2023-03-29
- HighOrthopedic Implant Recall: Excessive Radiation Exposure in Revision Tibial Insert
FDA (Devices) · 2023-03-29
- HighOrthopedic Tibial Insert Recalled Due to Excessive Radiation Exposure
FDA (Devices) · 2023-03-29
Same hazard · implant failure
See all →- HighStryker Hoffmann II Carbon Connecting Rods Recalled Over Potential Cracking After Sterilization
FDA (Devices) · 2026-08-05
- SeverePosterior Femoral Augment with Missing Screw Thread Recalled
FDA (Devices) · 2025-05-07
- SevereSmiths Medical ProPort Plastic Venous Access System Recalled
FDA (Devices) · 2025-03-26
- SevereSmiths Medical ProPort Implantable Port Housing May Separate Due to Manufacturing Defect
FDA (Devices) · 2025-03-26
- SevereSmiths Medical ProPort Implantable Port Component Separation Due to Manufacturing Defect
FDA (Devices) · 2025-03-26